BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 8
• 9
• 10
• 11
• 12

• Press Releases

  Alvotech enters supply and commercialization agreements for Canada and Australia & New Zealand covering multiple biosimilar candidates

  February 2, 2026

   · 

  4 min read
• Press Releases

  Breg and PatientIQ Announce Marketplace Partnership to Enhance Post-Operative Orthopedic Care Through EHR-Integrated Cold Therapy pathways

  February 2, 2026

   · 

  4 min read
• Press Releases

  Natera Submits Signatera™ CDx PMA to FDA

  February 2, 2026

   · 

  4 min read
• Press Releases

  Bavarian Nordic – Transactions in Connection with Share Buy-Back Program - February 2, 2026

  February 2, 2026

   · 

  2 min read
• Press Releases

  IDEAYA Biosciences to Participate in Upcoming February 2026 Investor Relations Events

  February 2, 2026

   · 

  2 min read
• Press Releases

  Eton Pharmaceuticals Announces Licensing of Rare Disease Product Candidate

  February 2, 2026

   · 

  3 min read
• Press Releases

  Iridex Announces Plans to Relocate Headquarters

  February 2, 2026

   · 

  3 min read
• Press Releases

  Harrow Reaffirms 2025 Full-Year Revenue Guidance of $270–$280 Million, Marking Another Year of Strong Growth

  February 2, 2026

   · 

  9 min read
• Press Releases

  EYLEA HD® (aflibercept) Injection 8 mg Presentations at Angiogenesis 2026 Underscore Strength of its Clinical Profile for the Treatment of Serious Retinal Diseases

  February 2, 2026

   · 

  14 min read
• Press Releases

  Sagimet Announces Positive 52-Week Data from License Partner Ascletis’ Open-Label Phase 3 Clinical Trial Evaluating the Long-Term Safety of ASC40 (Denifanstat) Tablets in Patients with Moderate to Severe Acne

  February 2, 2026

   · 

  8 min read